| B33 | Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study) | Oral abstract session with live Q&A | ART in highly treatment-experienced people |
| B33 | Transition to TLD leads to decreased rates of virologic failure among PLWH in sub-Saharan Africa | E-poster | ART in highly treatment-experienced people |
| B33 | Long-term (96-week) safety of fostemsavir (FTR) in heavily treatment-experienced (HTE) adults infected with multidrug-resistant (MDR) HIV-1 (BRIGHTE Phase 3 study) | E-poster | ART in highly treatment-experienced people |
| B33 | Weight changes in HIV+ individuals receiving ibalizumab over 96 weeks | E-poster | ART in highly treatment-experienced people |
| B33 | Clinical impact of antiretroviral agents used in optimized background therapy with fostemsavir in heavily treatment-experienced adults with HIV-1: exploratory analyses of the phase 3 BRIGHTE study | E-poster | ART in highly treatment-experienced people |
| B33 | Aggregating loss to follow-up behavior in Patients Living with HIV: a cluster analysis using unsupervised machine learning algorithm in R | E-poster | ART in highly treatment-experienced people |
| B62 | The road to success is paved with dolutegravir: Dolutegravir treatment success among in children and adolescents living with HIV (CALHIV) at the Baylor Tanzania Centres of Excellence | On-demand oral abstract session | ARV management strategies in paediatric and adolescent populations |
| B62 | There is no substitute for hard work(ing dolutegravir): outcomes of single drug substitutions among CALHIV shifted to a dolutegravir antiretroviral regimen in Mbeya and Mwanza, Tanzania | E-poster | ARV management strategies in paediatric and adolescent populations |
| B62 | High levels of drug-resistant HIV-1 among newly diagnosed antiretroviral treatment naïve infants in Uganda | E-poster | ARV management strategies in paediatric and adolescent populations |
| B62 | HIV minority resistance variants partially explain genotypic-phenotypic discordance | E-poster | ARV management strategies in paediatric and adolescent populations |